187 related articles for article (PubMed ID: 20457150)
1. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
Li YC; Ge LS; Yang PL; Tang JF; Lin JF; Chen P; Guan XQ
Eur J Pharmacol; 2010 Aug; 640(1-3):112-6. PubMed ID: 20457150
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Yue-Chun L; Li-Sha G; Jiang-Hua R; Peng-Lin Y; Jia-Feng L; Ji-Fei T; Peng C; Zhan-Qiu Y
J Cardiovasc Pharmacol; 2008 Jan; 51(1):92-8. PubMed ID: 18209574
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
Yue-Chun L; Teng Z; Na-Dan Z; Li-Sha G; Qin L; Xue-Qiang G; Jia-Feng L
PLoS One; 2012; 7(6):e39394. PubMed ID: 22761780
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
Wang D; Chen Y; Jiang J; Zhou A; Pan L; Chen Q; Qian Y; Chu M; Chen C
Gene; 2014 Sep; 547(2):195-201. PubMed ID: 24905653
[TBL] [Abstract][Full Text] [Related]
5. Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis.
Li-Sha G; Yi-He C; Na-Dan Z; Teng Z; Yue-Chun L
BMC Cardiovasc Disord; 2013 Nov; 13():100. PubMed ID: 24225056
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
Tschöpe C; Westermann D; Steendijk P; Noutsias M; Rutschow S; Weitz A; Schwimmbeck PL; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2004 May; 491(2-3):173-9. PubMed ID: 15140634
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
Nishio R; Shioi T; Sasayama S; Matsumori A
J Am Coll Cardiol; 2003 Jan; 41(2):340-5. PubMed ID: 12535832
[TBL] [Abstract][Full Text] [Related]
8. [Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):708-12. PubMed ID: 25001934
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol decreases elevated oxidative stress in human failing myocardium.
Nakamura K; Kusano K; Nakamura Y; Kakishita M; Ohta K; Nagase S; Yamamoto M; Miyaji K; Saito H; Morita H; Emori T; Matsubara H; Toyokuni S; Ohe T
Circulation; 2002 Jun; 105(24):2867-71. PubMed ID: 12070115
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Pauschinger M; Rutschow S; Chandrasekharan K; Westermann D; Weitz A; Peter Schwimmbeck L; Zeichhardt H; Poller W; Noutsias M; Li J; Schultheiss HP; Tschope C
Eur J Heart Fail; 2005 Jun; 7(4):444-52. PubMed ID: 15921778
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Yuan Z; Shioji K; Kihara Y; Takenaka H; Onozawa Y; Kishimoto C
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of carvedilol in experimental viral myocarditis.
Yue-Chun L; Li-Sha G; Xue-Qiang G; Jia-Feng L
Curr Pharm Des; 2012; 18(12):1620-4. PubMed ID: 22443630
[TBL] [Abstract][Full Text] [Related]
13. Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits.
Zubairi MB; Ahmed JH; Al-Haroon SS
Indian J Pharmacol; 2014; 46(6):644-8. PubMed ID: 25538338
[TBL] [Abstract][Full Text] [Related]
14. Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
Li YC; Luo Q; Ge LS; Chen YH; Zhou ND; Zhang T; Guan XQ; Lin JF
Biochem Biophys Res Commun; 2013 Feb; 431(3):450-5. PubMed ID: 23333383
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol improved diabetic rat cardiac function depending on antioxidant ability.
Huang H; Shan J; Pan XH; Wang HP; Qian LB; Xia Q
Diabetes Res Clin Pract; 2007 Jan; 75(1):7-13. PubMed ID: 16780994
[TBL] [Abstract][Full Text] [Related]
16. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
[TBL] [Abstract][Full Text] [Related]
17. Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
Fahlbusch SA; Tsikas D; Mehls C; Gutzki FM; Böger RH; Frölich JC; Stichtenoth DO
Eur J Clin Pharmacol; 2004 Apr; 60(2):83-8. PubMed ID: 15004731
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
Glück B; Dahlke K; Zell R; Krumbholz A; Decker M; Lehmann J; Wutzler P
J Med Virol; 2010 Dec; 82(12):2043-52. PubMed ID: 20981792
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
Castro P; Vukasovic JL; Chiong M; Díaz-Araya G; Alcaino H; Copaja M; Valenzuela R; Greig D; Pérez O; Corbalan R; Lavandero S
Eur J Heart Fail; 2005 Oct; 7(6):1033-9. PubMed ID: 16227141
[TBL] [Abstract][Full Text] [Related]
20. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H
J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
